123 related articles for article (PubMed ID: 7536131)
21. Loss of c-kit expression in cultured melanoma cells.
Lassam N; Bickford S
Oncogene; 1992 Jan; 7(1):51-6. PubMed ID: 1371338
[TBL] [Abstract][Full Text] [Related]
22. Phorbol ester 12-O-tetradecanoylphorbol-13-acetate down-regulates expression of the c-kit proto-oncogene product.
Asano Y; Brach MA; Ahlers A; de Vos S; Butterfield JH; Ashman LK; Valent P; Gruss HJ; Herrmann F
J Immunol; 1993 Sep; 151(5):2345-54. PubMed ID: 7689605
[TBL] [Abstract][Full Text] [Related]
23. Ectopic expression of c-kit in small-cell lung cancer.
Hida T; Ueda R; Sekido Y; Hibi K; Matsuda R; Ariyoshi Y; Sugiura T; Takahashi T; Takahashi T
Int J Cancer Suppl; 1994; 8():108-9. PubMed ID: 7515024
[TBL] [Abstract][Full Text] [Related]
24. Role for the stem cell factor/KIT complex in Schwann cell neoplasia and mast cell proliferation associated with neurofibromatosis.
Ryan JJ; Klein KA; Neuberger TJ; Leftwich JA; Westin EH; Kauma S; Fletcher JA; DeVries GH; Huff TF
J Neurosci Res; 1994 Feb; 37(3):415-32. PubMed ID: 7513766
[TBL] [Abstract][Full Text] [Related]
25. c-Met expression in tall cell variant papillary carcinoma of the thyroid.
Nardone HC; Ziober AF; LiVolsi VA; Mandel SJ; Baloch ZW; Weber RS; Mick R; Ziober BL
Cancer; 2003 Oct; 98(7):1386-93. PubMed ID: 14508824
[TBL] [Abstract][Full Text] [Related]
26. Wn mutation of c-kit receptor affects its post-translational processing and extracellular expression.
Koshimizu U; Tsujimura T; Isozaki K; Nomura S; Furitsu T; Kanakura Y; Kitamura Y; Nishimune Y
Oncogene; 1994 Jan; 9(1):157-62. PubMed ID: 7508100
[TBL] [Abstract][Full Text] [Related]
27. Expression of KIT, EGFR, HER-2 and tyrosine phosphorylation in undifferentiated thyroid carcinoma: implication for a new therapeutic approach.
Murakawa T; Tsuda H; Tanimoto T; Tanabe T; Kitahara S; Matsubara O
Pathol Int; 2005 Dec; 55(12):757-65. PubMed ID: 16287490
[TBL] [Abstract][Full Text] [Related]
28. Induction of nerve growth factor responsiveness in C6-2B glioma cells by expression of trkA proto-oncogene.
Colangelo AM; Fink DW; Rabin SJ; Mocchetti I
Glia; 1994 Oct; 12(2):117-27. PubMed ID: 7868185
[TBL] [Abstract][Full Text] [Related]
29. Induction of ETS-1 and ETS-2 transcription factors is required for thyroid cell transformation.
de Nigris F; Mega T; Berger N; Barone MV; Santoro M; Viglietto G; Verde P; Fusco A
Cancer Res; 2001 Mar; 61(5):2267-75. PubMed ID: 11280797
[TBL] [Abstract][Full Text] [Related]
30. Expression of the c-kit mRNA in human aortic endothelial cells.
Miyamoto T; Sasaguri Y; Sugama K; Azakami S; Morimatsu M
Biochem Mol Biol Int; 1994 Oct; 34(3):513-20. PubMed ID: 7530545
[TBL] [Abstract][Full Text] [Related]
31. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
Suzuki T; Muroi K; Tomizuka H; Amemiya Y; Miura Y
Stem Cells; 1995 May; 13(3):273-80. PubMed ID: 7542113
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident.
Fugazzola L; Pilotti S; Pinchera A; Vorontsova TV; Mondellini P; Bongarzone I; Greco A; Astakhova L; Butti MG; Demidchik EP
Cancer Res; 1995 Dec; 55(23):5617-20. PubMed ID: 7585643
[TBL] [Abstract][Full Text] [Related]
33. Expression of the ets-1 proto-oncogene in human thyroid tumor.
Nakayama T; Ito M; Ohtsuru A; Naito S; Nakashima M; Sekine I
Mod Pathol; 1999 Jan; 12(1):61-8. PubMed ID: 9950164
[TBL] [Abstract][Full Text] [Related]
34. Expression of c-kit protein in proliferative lesions of human breast: sexual difference and close association with phosphotyrosine status.
Tsuura Y; Suzuki T; Honma K; Sano M
J Cancer Res Clin Oncol; 2002 May; 128(5):239-46. PubMed ID: 12029439
[TBL] [Abstract][Full Text] [Related]
35. Complementary DNA cloning and characterization of truncated form of c-kit in human colon carcinoma cells.
Toyota M; Hinoda Y; Itoh F; Takaoka A; Imai K; Yachi A
Cancer Res; 1994 Jan; 54(1):272-5. PubMed ID: 7505199
[TBL] [Abstract][Full Text] [Related]
36. Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines.
Kitayama H; Kanakura Y; Furitsu T; Tsujimura T; Oritani K; Ikeda H; Sugahara H; Mitsui H; Kanayama Y; Kitamura Y
Blood; 1995 Feb; 85(3):790-8. PubMed ID: 7530509
[TBL] [Abstract][Full Text] [Related]
37. c-myc expression in the thyroid. I: Normal, adenomatous, and cancerous thyroid tissue.
Burman KD; Djuh YY; LaRocca RV; Nunes ME; D'Avis JC; Nicholson DE; Wartofsky L
Horm Metab Res Suppl; 1987; 17():63-5. PubMed ID: 3327800
[TBL] [Abstract][Full Text] [Related]
38. The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice.
Duttlinger R; Manova K; Berrozpe G; Chu TY; DeLeon V; Timokhina I; Chaganti RS; Zelenetz AD; Bachvarova RF; Besmer P
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3754-8. PubMed ID: 7537375
[TBL] [Abstract][Full Text] [Related]
39. Sustained c-kit expression in a human erythroleukemia cell line (HEL) after megakaryocytic differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA).
Bakić M; Ozawa K; Uemura N; Nishikawa M; Tojo A; Takahashi K; Tani K; Zaike Y; Ikebuchi K; Asano S
Leuk Res; 1993 Dec; 17(12):1079-82. PubMed ID: 7504152
[TBL] [Abstract][Full Text] [Related]
40. Expression of stem cell factor and c-kit in human neuroblastoma. The Children's Cancer Group.
Cohen PS; Chan JP; Lipkunskaya M; Biedler JL; Seeger RC
Blood; 1994 Nov; 84(10):3465-72. PubMed ID: 7524740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
